4//SEC Filing
THRESHOLD PHARMACEUTICALS INC 4
Accession 0001181431-12-011208
CIK 0001183765operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:29 PM ET
Size
16.8 KB
Accession
0001181431-12-011208
Insider Transaction Report
Form 4
Frazier Healthcare VI, L.P.
10% Owner
Transactions
- Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote)
FHM VI, L.P.
10% Owner
Transactions
- Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote)
FHM VI, L.L.C.
10% Owner
Transactions
- Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$5.38/sh−1,028,842$5,535,170→ 3,550,239 total - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote) - Sale
Common Stock
2012-02-21$6.02/sh−3,550,239$21,372,439→ 0 total(indirect: See Footnote)
Footnotes (5)
- [F1]These shares were sold by Frazier Healthcare VI, L.P. ("FH VI"). FHM VI, L.L.C. ("FHM VI L.L.C.") is the general partner of FHM VI., L.P. ("FHM VI"), which is the general partner of FH VI. FHM VI L.L.C. may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI L.L.C. disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
- [F2]These shares were sold by FH VI. FHM VI is the general partner of FH VI and may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
- [F3]These shares were sold by FH VI.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.98 to $5.98, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.985 to $6.465, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
THRESHOLD PHARMACEUTICALS INC
CIK 0001183765
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001183765
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:29 PM ET
- Size
- 16.8 KB